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Abstract
Both acute and chronic phases of Trypanosoma cruzi (T. cruzi) infection are
characterized by tissue inflammation, mainly in the heart. A key step in the
inflammatory process is the transmigration of inflammatory cells across the
endothelium to underlying infected tissues. We observed increased arachidonic
acid release and platelet-activating factor (PAF) production in human
coronary artery endothelial cells (HCAEC) at up to 96 h of T. cruzi infection.
Arachidonic acid release is mediated by activation of the calcium-independent
phospholipase A2 (iPLA2) isoforms iPLA2b and iPLA2c, whereas PAF produc-
tion was dependent upon iPLA2b activation alone. Trypanosoma cruzi infec-
tion also resulted in increased cell surface expression of adhesion molecules.
Increased adherence of inflammatory cells to T. cruzi-infected endothelium
was blocked by inhibition of endothelial cell iPLA2b or by blocking the PAF
receptor on inflammatory cells. This suggests that PAF, in combination with
adhesion molecules, might contribute to parasite clearing in the heart by
recruiting inflammatory cells to the endothelium.
Introduction
Trypanosoma cruzi is the protozoan parasite responsible for
Chagas’ disease, which is associated with significant cardiac
pathology. Over 10 million people worldwide are thought
to be currently infected with T. cruzi, and about 300,000
infected individuals live in the United States (Bern and
Montgomery 2009). The recent spread of the disease to sev-
eral nonendemic countries is attributable to immigration
from endemic areas, immunosuppression in the setting of
organ transplantation, and blood transfusions from infected
individuals. The acute phase of Chagas’ disease may not
cause symptoms, but in the chronic phase cardiac involve-
ment occurs in 20–30% of infected individuals and may
result in congestive heart failure, cardiac arrhythmias, and
death (Rassi et al. 2000; Bern 2011). A long asymptomatic
period separating acute and chronic phases is designated
the indeterminate phase and may persist for decades.
Interactions between the host and pathogen during
acute infection may determine the outcome of chronic
Chagas’ disease (Marinho et al. 1999). Parasite persistence
reflected by the presence of T. cruzi antigens and DNA in
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the heart have been found to correlate with the intensity
of chronic disease (Jones et al. 1993; Benvenuti et al.
2008), and it is therefore necessary to understand para-
site–host interactions in the acute phase of Chagas’ dis-
ease. A key pathological feature of T. cruzi infection is the
intense cardiac inflammation in both acute and chronic
stages. As a consequence of acute stage parasitemia, try-
pomastigotes migrate across endothelial barriers to infect
underlying tissues, resulting in increased expression of
vascular adhesion molecules and pro-inflammatory cyto-
kines when T. cruzi infects endothelial cells (Huang et al.
1999; Michailowsky et al. 2004). Infection of the endothe-
lium has a well-established role in the pathogenesis of
Chagas’ disease and contributes to increased platelet
aggregation and thrombus formation (Rossi et al. 1984;
Tanowitz et al. 1990).
Platelet-activating factor (PAF) is an important
membrane phospholipid-derived inflammatory mediator
expressed on the surface of endothelial cells, where it
plays an important role in the recruitment, activation,
and transmigration of leukocytes to sites of infection
(Prescott et al. 2002). PAF is an acetylated alkyl ether
glycerophosphocholine lipid species whose immediate
precursor is produced by the action of phospholipase A2
(PLA2) enzyme(s), and PAF can elicit biological responses
at concentrations as low as 1012 mol/L (Montrucchio
et al. 2000). The PLA2 family comprises enzymes that
hydrolyze phospholipids at the sn-2 position to yield a
free fatty acid and a 2-lysophospholipid. Lysophospho-
lipid species of the structure 1-O-alkyl, 2-lyso-glycer-
ophosphocholine (GPC) are designated lyso-PAF and
when acetylated in the sn-2 position yield PAF (McHowat
et al. 2001). When endothelial cell PAF interacts with the
PAF receptor expressed on the surface of leukocytes (Shi-
mizu et al. 1992), leukocytes become tethered to the
endothelium and activated leukocytes can transmigrate
into underlying tissues (Prescott et al. 2001).
We have shown that the major PLA2 in cardiac endo-
thelial cells is membrane associated, calcium-independent
(iPLA2), and specific for arachidonylated phospholipids
(Creer and McHowat 1998). Two iPLA2 isoforms (iPLA2b
and iPLA2c) are expressed by cardiac endothelial cells
(Sharma et al. 2011) and can be distinguished pharmaco-
logically. The (R) enantiomer of the compound BEL
(bromoenol lactone) preferentially inhibits iPLA2c, and
(S)-BEL preferentially iPLA2b (Jenkins et al. 2002). In
vitro studies using (R)- and (S)-BEL show that iPLA2b
activation results in PAF production, which is required
for neutrophil adherence to cardiac endothelium (White
and McHowat 2007; Sharma et al. 2011). Activated
cardiac endothelial cells from wild-type and iPLA2c
knockout mice produce PAF, but such cells from iPLA2b
knockout mice fail to do so (Sharma et al. 2011). This
suggests that iPLA2b may play an important role in
recruiting inflammatory cells to the myocardium by
enabling PAF production. Although downstream media-
tors generated from products of iPLA2 action have been
studied in Chagas’ disease, there has been no examination
of the contribution of individual iPLA2 isoforms to these
processes. We have therefore examined the contribution
of endothelial cell iPLA2b to inflammatory cell recruit-
ment following T. cruzi infection.
Materials and Methods
Human coronary artery endothelial cells
Human coronary artery endothelial cells (HCAEC) were
obtained from Lonza Walkersville, Inc. (Walkersville, MD).
Cells were grown to confluence in EGM-2MV media
obtained from Lonza (Walkersville, MD), with 5% fetal
bovine serum (FBS). Cells were allowed to grow to conflu-
ence achieving a contact-inhibited monolayer of flattened,
closely apposed endothelial cells in 4–5 days. After achiev-
ing confluence, cells were passaged in a 1:3 dilution and
cells from passages 3–4 were used for experiments.
Mouse endothelial cell isolation
Animal protocols were in strict accordance with the
National Institutes of Health guidelines for humane treat-
ment of animals and were reviewed and approved by the
Animal Care and Use Committee of Saint Louis Univer-
sity. Endothelial cells were isolated from mouse heart by
collagenase digestion. The diced heart muscle was incu-
bated in 2 mg/mL collagenase for 1 h at 37°C and the
digested tissue was passed through a cell strainer. Cells
were incubated with murine immunoglobulins to block
Fc receptors and then incubated with anti-mouse platelet
endothelial cell adhesion molecule-1 (PECAM-1) coupled
to magnetic beads. Cells obtained were cultured until they
reached confluence and sorted again using intercellular
adhesion molecule-2 (ICAM-2) antibodies coupled with
magnetic beads. The eluted cells were washed, resus-
pended in cell culture medium, and plated in culture.
Nonadherent cells were removed the next day and cells
were grown to confluence and passaged at a 1–3 dilution.
Parasitology
Tissue culture trypomastigotes (TCT) from the Brazil
strain of T. cruzi were propagated in 3T3 mouse embry-
onic fibroblasts grown in Dulbecco’s modified Eagle
medium (DMEM) supplemented with 2% neonatal calf
serum (Eickhoff et al. 2010). 3T3 cells were infected with
T. cruzi when 60% confluence was reached. Infected cells
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ruptured following parasite multiplication, releasing an
abundant number of parasites. The supernatant contain-
ing the parasites was collected, and parasite numbers
determined using a Neubauer hemocytometer (Patterson
Veterinary, Devens, MA). Cardiac endothelial cells, grown
to confluence in the appropriate culture dish were
counted and a multiplicity of infection (MOI) of 0.2 was
used to infect cells. In selected experiments, parasites
were killed by heating at 80°C for 10 min.
Phospholipase A2 activity
Endothelial cells were suspended in 1 mL buffer contain-
ing (mmol/L): Sucrose 250, KCL 10, imidazole 10, ethy-
lenediaminetetraacetic acid (EDTA) 5, dithiothreitol
(DTT) 2 with 10% glycerol, pH 7.8 (PLA2 activity buf-
fer). The suspension was sonicated on ice six times for
10 sec (using microtip probe at 20% power output, 500
Sonic Dismembrator; Fisher Scientific, Pittsburgh, PA)
and the sonicate centrifuged at 20,000g for 20 min to
remove cellular debris and nuclei. The pellet was resus-
pended in activity buffer. PLA2 activity was assessed by
incubating enzyme (50 lg protein) with 100 lmol/L
(16:0, [3H]18:1) plasmenylcholine substrate in assay buf-
fer containing (mmol/L): Tris 10, ethylene glycol tetra-
acetic acid (EGTA) 4, 10% glycerol, pH 7.0 at 37°C for
5 min in a total volume of 200 lL. The radiolabeled
phospholipid substrate was introduced into the incuba-
tion mixture by injection in 5 lL ethanol to initiate the
assay. Reactions were terminated by the addition of 100-
lL butanol and released radiolabeled [3H]oleic acid was
isolated by the application of 25 lL of the butanol
phase to channeled Silica Gel G plates, development
in the petroleum ether/diethyl ether/acetic acid (70/30/1,
v/v) and subsequent quantification by liquid scintillation
spectrometry. Protein content of each sample was deter-
mined by the Lowry method utilizing freeze-dried
bovine serum albumin as the protein standard.
Measurement of total arachidonic acid
release
Endothelial cells were incubated at 37°C with 3 lCi [3H]
arachidonic acid for 18 h. This incubation resulted in
>70% incorporation of radioactivity into membrane
phospholipids. Cells were fed with fresh medium contain-
ing [3H] arachidonic acid after 48 h where necessary.
After incubation, endothelial cells were washed three
times with Tyrode solution containing 0.36% bovine
serum albumin to remove unincorporated [3H] arachi-
donic acid. Endothelial cells were incubated at 37°C for
15 min before being subjected to experimental conditions.
At the end of the stimulation period the supernatant was
removed. Endothelial cells were lysed in 10% sodium
dodecyl sulfate, and radioactivity in both supernatant and
pellet was quantified by liquid scintillation spectrometry.
PAF assay
Endothelial cells grown in 12-well culture dishes were
washed twice with Hanks’ balanced salts solution contain-
ing NaCl 135 mmol/L, MgSO4 0.8 mmol/L, HEPES (pH
= 7.4) 10 mmol/L, CaCl2 1.2 mmol/L, KCl 5.4 mmol/L,
KH2PO4 0.4 mmol/L, Na2HPO4 0.3 mmol/L, and glucose
6.6 mmol/L and incubated with 50 lCi [3H] acetic acid
for 20 min. After the selected time interval for incubation
with the appropriate agents, lipids were be extracted from
the cells by the method of Bligh and Dyer (1959). The
chloroform layer was concentrated by evaporation under
N2, applied to a silica gel 60 thin layer chromatography
(TLC) plate, and developed in chloroform/methanol/ace-
tic acid/water (50/25/8/4 vol/vol). The region correspond-
ing to PAF was scraped and radioactivity quantified using
liquid scintillation spectrometry. Loss of PAF during
extraction and chromatography was corrected for by add-
ing a known amount of [14C] PAF as an internal stan-
dard. [14C] PAF was synthesized by acetylating the sn-2
position of lyso-PAF with [14C] acetic anhydride using
0.33 mol/L dimethylaminopyridine as a catalyst. The syn-
thesized [14C] PAF was purified by high-performance
liquid chromatography (HPLC).
Inflammatory cell adherence
RAW 264.7 cells were grown to confluence in DMEM with
10% FBS. Cell suspensions (10 9 106/mL) were labeled
with 4 lg/mL calcein-AM for 45 min at 37°C. Cells were
washed three times with HEPES buffer, resuspended at a
concentration of 4 9 106/mL and 0.5 mL was added to
confluent mouse cardiac myocyte cell layer. At the end of
the incubation time, nonadherent cells were removed and
adherent cells and cardiac myocytes were lysed in 1 mL of
0.2% Triton X-100. Calcein fluorescence in each sample
was measured at an excitation wavelength of 485 nm and
an emission wavelength of 530 nm. The percent cell adher-
ence in each sample was calculated based upon the fluores-
cence measured in 0.5 mL of RAW 264.7 cell suspension.
Polymorphonuclear leukocyte (PMN)
adherence
Blood (80 mL) was obtained from healthy adults and lay-
ered over an equal volume of Polymorphprep (AxisShield,
Oslo, Norway) in 50-mL conical tubes. Tubes were spun
at 500 g for 30 min at 20°C. The buffy coat at the sam-
ple–medium interface consisting of PMN was removed,
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washed, and resuspended in 5 mL of ice-cold Hank’s
balanced salt solution (HBSS), and cells were counted.
HCAEC grown on a 12-mm plate were washed twice with
HBSS. After appropriate pretreatment of endothelial cells
or PMN, 0.5 mL of PMN suspension (4 9 106 cells/mL)
in HBSS was added to each of the wells and incubated for
10 min at room temperature. Medium and unbound cells
were removed and discarded. Plates were washed twice with
prewarmed Dulbecco’s phosphate-buffered saline (DPBS).
Adherent PMN and endothelial cells were lysed in 1 mL of
0.2% Triton X-100. For maximal binding, a 0.5-mL aliquot
of PMN suspension plus 0.5 mL of 0.2% Triton X-100 was
used. To measure myeloperoxidase activity, we added
400 lL of cell lysate to 1 mL of phosphate-buffered saline
(PBS), 1.2 mL of Hanks’ buffer-bovine serum albumin
(BSA), and 0.2 mL of 3,3-dimethoxybenzidine, and 0.2 mL
of 0.05% H2O2 was added. After 15 min, 0.2 mL of 1%
NaN3 was added to stop the reaction, and absorbance was
measured using a 4050 ultraviolet/Visible spectrophotome-
ter (Biochrom, Cambridge, UK) at 460 nm.
Surface expression of adhesion molecules
HCAEC were grown to confluence in 16-mm culture
dishes and were incubated with T. cruzi (MOI 0.2) for up
to 96 h. At the end of the incubation, cells were fixed
with 1% paraformaldehyde and incubated overnight at
4°C. Cells were then washed three times with PBS and
then blocked with Tris-buffered saline-Tween supple-
mented with 0.8% BSA (wt/vol) and 0.5% fish gelatin
(wt/vol) for 1 h at 24°C. Appropriate primary antibody
(1:50; Santa Cruz Biotechnology, Santa Cruz, CA) was
used before treatment with horseradish peroxidase-conju-
gated rabbit anti-goat secondary antibody (1:5,000; Santa
Cruz Biotechnology, Santa Cruz, CA). Subsequently, each
well was incubated in the dark with the 3,3′,5,5′-tetra-
methylbenzidine liquid substrate system and color devel-
opment measured at 450 nm.
Statistical analysis
Statistical comparison of values was performed by stu-
dent’s t-test or one-way analysis of variance with post hoc
analysis performed using Dunnet’s test. All results are
expressed as mean  SEM. Statistical significance was
considered to be P < 0.05.
Results
Trypanosoma cruzi infection of HCAEC
HCAEC were incubated with T. cruzi for up to 96 h and
iPLA2 activity, arachidonic acid release, PAF production,
and expression of cell surface adhesion molecules were
measured (Fig. 1). Trypanosoma cruzi (MOI 0.2) infection
of HCAEC increased PLA2 activity measured in the pres-
ence of 10 mmol/L EGTA (iPLA2 activity) that was signif-
icant after 24 h of infection and remained increased over
96 h (Fig. 1A). Accompanying the increase in iPLA2
activity, we measured a significant increase in arachidonic
acid release (Fig. 1B) and PAF production (Fig. 1C).
When HCAEC were incubated with heat-killed T. cruzi,
no significant changes in iPLA2 activity, arachidonic acid
release, or PAF production were observed (Fig. 1A–C).
Adhesion molecules expressed on the surface of endo-
thelial cells could significantly contribute to inflammatory
cell adherence and transmigration, and may work
synergistically with PAF. After infection of HCAEC with
T. cruzi, we observed increased cell surface expression of
intercellular adhesion molecule-1 (ICAM-1), vascular cell
adhesion molecule-1 (VCAM-1), and E-selectin (Fig. 1C)
prior to the observed increase in PAF production
(Fig. 1C). As adhesion molecules are upregulated imme-
diately after infection, they could contribute to the initial
tethering of inflammatory cells to the endothelium prior
to attachment and activation via the PAF–PAF receptor
interaction. The involvement of multiple molecules high-
lights the importance of the recruitment of circulating
leukocytes, and this redundancy may allow for compensa-
tion in the absence of any single adhesion molecule.
To determine which iPLA2 isoform was involved in T.
cruzi-mediated arachidonic acid and PAF production, we
pretreated HCAEC with (R)- or (S)-BEL to inhibit iPLA2c
or iPLA2b selectively (Jenkins et al. 2002) prior to infection
with T. cruzi. Treatment with (R)- or (S)-BEL resulted in a
significant reduction in basal iPLA2 activity and inhibition
of iPLA2 activation in response to T. cruzi infection
(Fig. 2A). Inhibition of iPLA2b activity with (S)-BEL was
significantly greater than corresponding concentrations of
(R)-BEL used to inhibit iPLA2c (Fig. 2A), suggesting that
iPLA2b activity is predominant in HCAEC.
We measured arachidonic acid release and PAF pro-
duction in the presence or absence of (R)- or (S)-BEL at
48 h post infection with T. cruzi. Endothelial cells showed
a significant increase in arachidonic acid release (Fig. 2B)
and PAF production (Fig. 2B) in response to T. cruzi
infection. Although arachidonic acid release was inhibited
by similar extent by (R)- or (S)-BEL (Fig. 2B), PAF pro-
duction was unaffected by (R)-BEL pretreatment and
completely inhibited by (S)-BEL pretreatment (Fig. 2C).
Hence, our data suggest that T. cruzi-induced arachidonic
acid release is mediated by activation of both iPLA2b and
iPLA2c, whereas increased PAF production is entirely
dependent upon iPLA2b activation.
To examine the effects of iPLA2b-mediated PAF produc-
tion on inflammatory cell adherence to the endothelium,
2014 | Vol. 2 | Iss. 1 | e00196
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human PMNs were isolated from peripheral blood and
incubated with HCAEC infected with T. cruzi. PMN
adherence to HCAEC was assessed at 24, 48, 72, and 96 h
thereafter. A time-dependent increase in PMN adherence
was observed in infected HCAEC, and maximum adher-
ence was observed 48 h after infection with 0.2 MOI of
T. cruzi (Fig. 2D). Pretreating HCAEC with (S)-BEL prior
to infection resulted in a significant reduction in neutro-
phil adherence, and reduced adherence was also observed
when PMN were treated with the PAF receptor antagonist
CV3988 (Fig. 2D). Thus, the interaction of endothelial cell
PAF with the PAF receptor on inflammatory cells is critical
for inflammatory cell adherence to endothelium.
To further demonstrate involvement of iPLA2b activa-
tion in increased PAF production in T. cruzi-infected
endothelium, cardiac endothelial cells were isolated from
wild-type and iPLA2b knockout mice. Confluent mono-
layers of these cells were stained for coagulation factor
VIII, which is an endothelial cell-specific marker
expressed by more than 80% of the cultured cells (data
not shown). After pretreatment with either (R)- or (S)-
BEL, endothelial cells were infected with T. cruzi (MOI
0.2) for 48 h and PAF production was measured. Infec-
tion with T. cruzi resulted in a significant increase in PAF
production by wild-type cardiac endothelial cells
(Fig. 3A). Pretreatment of wild-type endothelial cells with
(S)-BEL significantly inhibited the T. cruzi-induced pro-
duction of PAF, whereas pretreatment with (R)-BEL had
much less of an effect (Fig. 3A). No increase in PAF was
observed when iPLA2b-KO cardiac endothelial cells were
2 4 8 12 24 48 72
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Figure 1. Changes in calcium-independent phospholipase A2 (iPLA2) activity (A), arachidonic acid release (B), platelet-activating factor (PAF)
production (C), and cell surface expression of ICAM-1, VCAM-1, and E-selectin (D) in human coronary artery endothelial cells infected with
Trypanosoma cruzi (MOI 0.2, untreated ● or heat-killed □ in A–C) for up to 96 h. Values shown are means  SEM for four separate cell
cultures. *P < 0.05, **P < 0.01 when compared to uninfected controls.
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infected with T. cruzi. These data suggest that iPLA2b is
required for mouse cardiac endothelial cell PAF produc-
tion induced by infection with T. cruzi. Adherence of
RAW 264.7 murine macrophage/monocyte cells to cardiac
endothelial cells isolated from wild-type and iPLA2b-KO
mice following infection with T. cruzi was determined
(Fig. 3B). After 48 h, infected wild-type endothelial cells
exhibited a significant increase in RAW 264.7 cell adher-
ence compared to uninfected cells (Fig. 3B). Pretreatment
with the iPLA2b inhibitor (S)-BEL resulted in a marked
reduction in RAW 264.7 cell adherence to T. cruzi-
infected wild type cardiac endothelial cells (Fig. 3B). No
increased adherence of RAW 264.7 cells to iPLA2b-KO
cardiac endothelial cells was observed after infection with
T. cruzi in the presence or absence of (S)-BEL (Fig. 3B).
Pretreatment of RAW 264.7 cells with the PAF receptor
antagonist CV3988 prior to addition to T. cruzi-infected
endothelial cells resulted in complete inhibition of RAW
264.7 cell adherence to the cardiac endothelial cells under
all experimental conditions (Fig. 3B). Thus, the increase
in RAW 264.7 cell adherence to T. cruzi-infected endothe-
lial cells requires iPLA2b-mediated PAF production.
Discussion
Previous studies have indicated that iPLA2b is responsible
for the majority of cardiac endothelial cell iPLA2 activity
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Figure 2. Calcium-independent phospholipase A2 (iPLA2) activity (A), arachidonic acid release (B), platelet-activating factor (PAF) production
(C), and adherence of polymorphonuclear leukocytes (PMN) (D) in human coronary artery endothelial cells infected with Trypanosoma cruzi
(MOI 0.2) for up to 96 h. Cells were pretreated with 0.5 lmol/L (R)-bromoenol lactone (BEL) or (S)-BEL (10 min) prior to infection with T. cruzi.
Values shown are means  SEM for four separate cell cultures. **P < 0.01 when compared with uninfected controls. ++P < 0.01 when
comparing values in the presence or absence of BEL.
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endothelial cell iPLA2b by the proteases thrombin or
tryptase results in PAF production (Sharma et al. 2011).
PAF is considered an important mediator in regulating
the transmigration of inflammatory cells across the endo-
thelium and in facilitating their recruitment to areas of
injury or infection (Prescott et al. 2002). Endothelial cell
surface PAF interacts with the PAF receptor on the sur-
face of inflammatory cells, and this results in activation,
adhesion, and migration of leukocytes. Activated leuko-
cytes generate reactive oxygen species, cytokines, and deg-
radative enzymes at the site of injury in an attempt to
restrict and eliminate the inflammatory stimulus, but
these mediators can cause excessive inflammation that
leads to tissue damage. Thus, these processes must be
carefully regulated.
Our studies were designed to determine the role of
endothelial cell iPLA2b during acute T. cruzi infection.
Studies with HCAEC demonstrate that there is increased
endothelial cell PAF production after infection with
T. cruzi that requires iPLA2b (Fig. 2A). A corresponding
increase in PMN adherence to the endothelium is also
observed in this context (Fig. 2D). Pharmacological inhi-
bition of iPLA2b with (S)-BEL resulted in inhibition of
PMN adherence to T. cruzi-infected HCAEC (Fig. 2D).
Additionally, blockade of the PAF-R with the antagonist
CV3988 on the PMN surface resulted in decreased adher-
ence of neutrophils to the endothelium in both unin-
fected and T. cruzi-infected HCAEC (Fig. 2D). These
results highlight the importance of the interaction
between endothelial cell PAF and PAF-R on the inflam-
matory cell surface for adherence of inflammatory cells to
the endothelium and hence their subsequent recruitment
to the appropriate site.
Infecting HCAEC with T. cruzi resulted in an increase
in cell surface expression of adhesion molecules as early
as 4 h post infection, with a later increase in PAF produc-
tion at 24 h. However, PMN adherence was not signifi-
cantly increased until 48 h post infection. The time
course of PMN adherence correlated with that for PAF
accumulation rather than upregulation of adhesion mole-
cules. There are multiple mediators involved in leukocyte
adhesion and transmigration across the endothelium, and
such biological redundancy underscores the importance
of this process. Thus, even though our data indicate that
PAF appears to be critical for this process in vitro, it is
possible that its absence alone may not significantly affect
cardiac inflammation in vivo. A number of reported
observations indicate that adhesion molecules expressed
on the endothelial cell surface are also important in leu-
kocyte recruitment. Tanowitz et al. have demonstrated
that infection of human umbilical vein endothelial cells
(HUVECs) with T. cruzi results in NF-jB activation and
that this leads to an increased expression of adhesion
molecules (Huang et al. 1999). Michailowsky et al. (2004)
have demonstrated that interferon c (IFNc) induces
expression of adhesion molecules by vascular endothelium
and that ICAM-1 plays a critical role in leukocyte migra-
tion in acute T. cruzi infection.
Chronic Chagas’ disease is associated with cardiomyop-
athy involving impaired endothelial cell function that can
contribute to microvascular abnormalities such as focal
ischemia or microthrombus formation. Recently, Molina-
Berrios et al. (2013) demonstrated the presence of endo-
thelial cell dysfunction markers, including soluble forms







































































Figure 3. PAF production (A) and RAW 264.7 cell adherence (B) in
Trypanosoma cruzi infected (MOI 0.2, 48 h) wild-type or iPLA2b
knockout endothelial cells following (R)- or (S)-BEL pretreatment
(0.5 lmol/L, 10 min). *P < 0.05, **P < 0.01 when compared to
uninfected cells. +P < 0.05, ++P < 0.01 when comparing values in
the presence or absence of BEL. Values shown are mean + SEM for
six separate cell cultures.
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mice after 90 days of infection. Prolonged endothelial cell
activation in chronic Chagas’ disease may also be associ-
ated with increased PAF production as a result of iPLA2
activation.
Studies using endothelial cells isolated from hearts of
wild-type and iPLA2b knockout mice also indicated that
iPLA2b is necessary for T. cruzi-induced PAF produc-
tion (Fig. 3A). Wild-type cardiac endothelial cells pro-
duced greater amounts of PAF after infection with
T. cruzi, and this was prevented by pretreatment with
the iPLA2b inhibitor (S)-BEL. Endothelial cells isolated
from iPLA2b-knockout mice failed to increase PAF pro-
duction after T. cruzi infection. Similarly, mouse RAW
264.7 macrophage-like cells also exhibited increased
adherence to mouse cardiac endothelial cells with the
rise in iPLA2b-mediated PAF production that occurred
after T. cruzi infection (Fig. 3B). Taken together, these
studies suggest that iPLA2b deficiency results in reduced
endothelial cell PAF production and that this might
impair recruitment of inflammatory cells to cardiac tis-
sue in the acute and chronic phases of Chagas’ disease.
Although our data indicate that the absence of iPLA2b
results in impaired PMN adherence via reduced endo-
thelial cell PAF production, iPLA2-mediated hydrolysis
of membrane phospholipids results in the direct or
indirect production of several inflammatory metabolites
(Six and Dennis 2000; Burke and Dennis 2009; Dennis
et al. 2011). Thus, we cannot rule out that other
iPLA2b-catalyzed metabolites are not involved in PMN
adherence. We have demonstrated previously that the
absence of iPLA2b does not inhibit coronary artery
endothelial cell eicosanoid generation completely
(Sharma et al. 2011), but we have shown that lys-
oplasmenylcholine increases PMN adherence and cell
surface expression of adhesion molecules (White et al.
2007). Thus, it is likely that other downstream metabo-
lites of iPLA2b-catalyzed membrane phospholipid hydro-
lysis may play a role in inflammatory cell adherence to
the endothelium.
In conclusion, our data demonstrate that T. cruzi infec-
tion of endothelial cells results in iPLA2b activation and
increased PAF production. Pretreatment of endothelial
cells with an iPLA2b inhibitor or inflammatory cells with
a PAF receptor antagonist demonstrate that blocking the
PAF–PAF receptor interaction is sufficient to inhibit
adherence of inflammatory cells to the endothelium in
vitro; however, further studies are warranted to determine
whether the absence of endothelial cell iPLA2b results in
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